HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Summary Full Text Free Full Text (PDF) Free All Versions of this Article: fj.06-6252fjev1 20/14/2556    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Budas, G. R. Articles by Jovanovic, A. Search for Related Content PubMed PubMed Citation Articles by Budas, G. R. Articles by Jovanovic, A.

3'phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium

Grant R. Budas^*, Andrey Sukhodub^*, Dario R. Alessi and Aleksandar Jovanovi^*,1

^* Maternal and Child Health Sciences, Ninewells Hospital and Medical School, and

MRC Protein Phosphorylation Unit, School of Life Sciences, University of Dundee, Dundee, Scotland, UK

¹Correspondence: Maternal and Child Health Sciences, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, Scotland, UK. E-mail: a.jovanovic{at}dundee.ac.uk

ABSTRACT

Brief periods of ischemia and reperfusion that precede sustained ischemia lead to a reduction in myocardial infarct size. This phenomenon, known as ischemic preconditioning, is mediated by signaling pathway(s) that are yet to be fully defined. 3'-phosphoinositide-dependent kinase-1 (PDK1) has been implicated in numerous cellular processes. However, the involvement of PDK1 in preconditioning has yet to be elucidated. Studying PDK1 is not as straightforward as it is for the majority of kinases, due to the lack of a specific inhibitor of PDK1. Therefore, we have taken advantage of PDK1 hypomorphic mutant mice with reduced expression of PDK1 to study the role of PDK1 in preconditioning. Whole heart and single cell models of preconditioning demonstrated that the hearts and cardiac cells from PDK1 hypomorphic mice could not be preconditioned. The cardioprotective effect of PDK1 was not related to the effect that preconditioning has on sarcolemmal membrane action potential as revealed by di-8-ANEPPS, a sarcolemmal-potential sensitive dye, and laser confocal microscopy. In contrast, experiments with JC-1, a mitochondrial membrane potential-sensitive dye, has demonstrated that intact PDK1 levels were required for preconditioning-mediated regulation of mitochondrial membrane potential. Western blotting combined with functional experiments have shown that intact PDK1 levels were required for preconditioning-induced phosphorylation of protein kinase B (PKB), glycogen synthase kinase-3ß (GSK-3ß), and cardioprotection. We conclude that PDK1 mediates preconditioning in the heart by regulating activating PKB-GSK-3ß to regulate mitochondrial but not sarcolemmal membrane potential. 3'phosphoinositide-dependent kinase-1 (PDK1) is essential for ischemic preconditioning of the myocardium.—Budas, G.R., Sukhodub, A., Alessi, D.R., Jovanovic, A. 3'phosphoinositide-dependent kinase-1 is essential for ischemic preconditioning of the myocardium.

This article has been cited by other articles:

				K. V. Routhu, N. E. Tsopanoglou, and J. L. Strande Parstatin(1-26): The Putative Signal Peptide of Protease-Activated Receptor 1 Confers Potent Protection from Myocardial Ischemia-Reperfusion Injury J. Pharmacol. Exp. Ther., March 1, 2010; 332(3): 898 - 905. [Abstract] [Full Text] [PDF]

				J. L. Strande, M. E. Widlansky, N. E. Tsopanoglou, J. Su, J. Wang, A. Hsu, K. V. Routhu, and J. E. Baker Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury Cardiovasc Res, July 15, 2009; 83(2): 325 - 334. [Abstract] [Full Text] [PDF]

				K. Ito, H. Akazawa, M. Tamagawa, K. Furukawa, W. Ogawa, N. Yasuda, Y. Kudo, C.-h. Liao, R. Yamamoto, T. Sato, et al. PDK1 coordinates survival pathways and {beta}-adrenergic response in the heart PNAS, May 26, 2009; 106(21): 8689 - 8694. [Abstract] [Full Text] [PDF]

				K. Ban, A. J. Cooper, S. Samuel, A. Bhatti, M. Patel, S. Izumo, J. M. Penninger, P. H. Backx, G. Y. Oudit, and R. G. Tsushima Phosphatidylinositol 3-Kinase {gamma} Is a Critical Mediator of Myocardial Ischemic and Adenosine-Mediated Preconditioning Circ. Res., September 12, 2008; 103(6): 643 - 653. [Abstract] [Full Text] [PDF]

				E. Murphy and C. Steenbergen Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury Physiol Rev, April 1, 2008; 88(2): 581 - 609. [Abstract] [Full Text] [PDF]

				Z. Cai, H. Zhong, M. Bosch-Marce, K. Fox-Talbot, L. Wang, C. Wei, M. A. Trush, and G. L. Semenza Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1{alpha} Cardiovasc Res, February 1, 2008; 77(3): 463 - 470. [Abstract] [Full Text] [PDF]

				K. Ytrehus Hypoxia-inducible factor 1{alpha}: a new piece in the preconditioning puzzle Cardiovasc Res, February 1, 2008; 77(3): 443 - 444. [Full Text] [PDF]